Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,209,500 papers from all fields of science
Search
Sign In
Create Free Account
KIH 802
Known as:
KIH-802
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
2-nitroimidazole-1-acetohydroxamic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics
K. Sasai
,
Y. Shibamoto
,
+6 authors
M. Abe
Cancer Chemotherapy and Pharmacology
2008
Corpus ID: 1792369
SummaryThe radiosensitizing activity, acute toxicity, and pharmacokinetics of a new hypoxic cell radiosensitizer, potassium 2…
Expand
1992
1992
Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
H. Nagasawa
,
M. Bando
,
+4 authors
S. Inayama
International Journal of Radiation Oncology…
1992
Corpus ID: 12078054
1990
1990
[Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
C. Murayama
,
T. Mori
Gan no rinsho. Japan journal of cancer clinics
1990
Corpus ID: 10342932
Because of the unsuccessful clinical trials of misonidazole (MISO), many efforts have been made to find a new hypoxic cell…
Expand
1989
1989
KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
H. Hori
,
C. Murayama
,
+4 authors
S. Inayama
International Journal of Radiation Oncology…
1989
Corpus ID: 40582877
Review
1989
Review
1989
[Present status of radiation sensitizers--hypoxic cell radiosensitizer].
C. Murayama
,
T. Mori
Gan to kagaku ryoho. Cancer & chemotherapy
1989
Corpus ID: 10741404
There is a world-wide demand for a clinically usable sensitizer for radio resistant hypoxic cells. Since the unsuccessful…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE